findmyKOL

Ari Klapholz, MD

Basic profile

Cabrini Medical Center

ORCIDNone on fileNPI
RegionNew York, NY · NortheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2014Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ari Klapholz is a Respiratory physician affiliated with Cabrini Medical Center. OpenAlex indexes 18 publications with 201 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
18publications

Distinct works indexed by OpenAlex.

201citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

275 7th Avenue
3rd Floor
New York, NY 10001

Telephone

646-660-9999

Provider last certified this registry record 5 Apr 2021.

View the NPPES registry record

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    63%
    Corticosteroid42.9%
    Trelegy Ellipta65%Symbicort8%Breztri Aerosphere7%Breo Ellipta6%Budesonide-Formoterol Fumarate6%Breyna3%Qvar Redihaler3%Fluticasone Propionate2%
    Part D<11 patients
    beta2-Adrenergic Agonist17.1%
    Albuterol Sulfate Hfa88%Ventolin Hfa12%
    Part D52 patients

    + 1 more class in this area

  • Nervous system

    28.5%
    gamma-Aminobutyric Acid A Receptor Positive Modulator8.8%
    Zolpidem Tartrate100%
    Part D23 patients
    Gabapentinoids4.6%
    Gabapentin100%
    Part D13 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    5.8%
    Corticosteroid5.8%
    Prednisone100%
    Part D30 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”